SuperworthCompass Therapeutics shares outstanding CMPX
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Mar 31, 2025
- 138.2M
Compass Therapeutics had 138.2M diluted shares outstanding on average in Q1 FY25, the quarter to Mar 31, 2025.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2024 | 137.7M | +60% |
| FY2021 | 86.2M | +1111% |
| FY2020 | 7.1M | −86% |
| FY2020 | 51.1M | +921% |
| FY2019 | 5M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q1 FY25 | 138.2M | n/a | |
| Q4 FY24 | 137.7M | n/a | |
| Q3 FY24 | 137.6M | n/a | |
| Q1 FY22 | 100.9M | +97% | |
| Q4 FY21 | 86.2M | +1111% | |
| Q3 FY21 | 61.7M | +1134% | |
| Q2 FY21 | 51.9M | +669% | |
| Q1 FY21 | 51.3M | +676% | |
| Q4 FY20 | 51.1M | +921% | |
| Q3 FY20 | 50.9M | +919% | |
| Q1 FY20 | 13.6M | +172% | |
| Q4 FY20 | 7.1M | +42% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Compass Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.